Skip to content
Tuesday, November 10, 2026
SimplyBlog

Zimbabwe Declines ‘Lopsided’ US Healthcare Assistance Agreement Because of Data Concerns

Medical aid illustration
The offered US financial assistance would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has rejected a substantial American health deal valued at $367m (272 million pounds) over five years because of Washington's request for sensitive data.

This rejection came to light following a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".

A government representative later stated that the United States was requesting health data for scientific study and profit while was unwilling to guarantee the resulting advantages from any future vaccines.

"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for further talks to reach a deal acceptable to all parties so the country's critical HIV treatment initiative can be sustained.

Wider Implications

This rejection follows a comparable situation in Kenya, where a high court halted a related deal with the US following legal challenges were filed about the security of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.

The agency had administered aid for the US government, but Trump stated its spending was "wasteful" and his administration was seeking direct bilateral deals to enhance transparency and accountability.

According to statements, Sixteen nations in Africa have so far signed these new health pacts, constituting over $18.3bn of fresh investment.

Details of the Declined Agreement

The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on antiretroviral therapy via US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".

"Our nation was requested to provide its biological resources and data over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," he stated.

"Effectively, our nation would provide the raw materials for medical research with no certainty that the resulting innovations would be accessible to our people should a future pandemic emerge."

Sovereignty and Global Health

Mangwana further pointed out that the US's withdrawal from the global health body and its push of bilateral deals were disrupting frameworks already established via the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage future pandemics.

"This system is designed to guarantee that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to create them."

The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We are open to ongoing dialogue with our US partners on how future collaboration might be structured in a manner that honours the sovereignty and dignity of both nations."

Health Experts Reaction

A leading public health body said it acknowledged the government's concerns, but recommended that negotiations need to persist since a large portion of the country's HIV programmes were funded by foreign aid.

"Where specific concerns arise, such as those relating to information security or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group said.

This impasse underscores the continuing debate between receiving much-needed international aid and safeguarding a country's data in an ever more interconnected world.

By

Stephanie Woods

A lifestyle writer and wellness coach passionate about helping others find balance and joy in everyday moments.

SimplyBlog

Type to search articles.